Article Information
vol. 57 no. 2
PubMed
出版ished By
Print ISSN
Online ISSN
History
- Received December 20, 2019
- Accepted August 13, 2020
- 出版ished onlineFebruary 4, 2021.
Article Versions
- previous version (September 3, 2020 - 08:29).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©ERS 2021
Author Information
- Steven P. Cass1,
- Yuqiong Yang2,
- Jing Xiao3,
- Joshua J.C. McGrath1,
- Matthew F. Fantauzzi1,
- Danya Thayaparan1,
- Fengyan Wang3,
- Zhenyu Liang2,
- Fei Long3,
- Christopher S. Stevenson4,
- Rongchang Chen2,5and
- Martin R. Stampfli2,6,7
- 1Medical Sciences Graduate Program, McMaster University, Hamilton, ON, Canada
- 2呼吸疾病国家重点实验室,国家nal Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, P.R. China
- 3State Key Laboratory of Respiratory Disease, Sino-French Hoffmann Institute, College of Basic Medical Science, Guangzhou Medical University, Guangzhou, P.R. China
- 4Janssen Disease Interception Accelerator, Janssen Pharmaceutical Companies of Johnson and Johnson, Raritan, NJ, USA
- 5Shenzhen Institute of Respiratory Diseases, Shenzhen People's Hospital, Shenzhen, P.R. China
- 6Dept of Pathology and Molecular Medicine, McMaster Immunology Research Centre, McMaster University, Hamilton, ON, Canada
- 7Dept of Medicine, Firestone Institute of Respiratory Health at St. Joseph's Health Care, McMaster University, Hamilton, ON, Canada
- Martin R. Stampfli, Dept of Pathology and Molecular Medicine, McMaster Immunology Research Centre, McMaster University, MDCL Room 4011, 1200 Main Street, West Hamilton, ON L8N 3Z5, Canada. E-mail:stampfli{at}mcmaster.ca
Funding
-
Janssen Pharmaceuticals
RespiVert Ltd -
Guangzhou Healthcare Collaborative Innovation Major Project
201604020012 -
National Key R&D Program of China
2017YFC1310600 -
Institute of Circulatory and Respiratory Health
PJT-159792 -
广东医学研究基金会
C2017050